These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7527810)

  • 21. Increasing immunogenicity of antigens fused to Ig-binding proteins by cell surface targeting.
    Léonetti M; Thai R; Cotton J; Leroy S; Drevet P; Ducancel F; Boulain JC; Ménez A
    J Immunol; 1998 Apr; 160(8):3820-7. PubMed ID: 9558086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells.
    Fukasawa M; Adachi H; Hirota K; Tsujimoto M; Arai H; Inoue K
    Exp Cell Res; 1996 Jan; 222(1):246-50. PubMed ID: 8549669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scavenger receptor-mediated recognition of maleyl bovine plasma albumin and the demaleylated protein in human monocyte macrophages.
    Haberland ME; Fogelman AM
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2693-7. PubMed ID: 3857610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
    Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
    Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The response of T cells to soluble protein antigens and fixed antigen-presenting cells.
    Bujdoso R; Munro AJ
    Immunology; 1986 Sep; 59(1):51-5. PubMed ID: 2428735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avian T helper one/two immune response balance can be shifted toward inflammation by antigen delivery to scavenger receptors.
    Vandaveer SS; Erf GF; Durdik JM
    Poult Sci; 2001 Feb; 80(2):172-81. PubMed ID: 11233005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-pulsed macrophage monolayers as specific immunoabsorbents: selective absorption of murine T cells committed to soluble protein antigen.
    Langdon WY; Holt PG; Shellam GR
    Immunology; 1981 Jul; 43(3):555-62. PubMed ID: 6166549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The macrophage scavenger receptor type A directs modified proteins to antigen presentation.
    Nicoletti A; Caligiuri G; Törnberg I; Kodama T; Stemme S; Hansson GK
    Eur J Immunol; 1999 Feb; 29(2):512-21. PubMed ID: 10064066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scavenger-receptor targeted photodynamic therapy.
    Hamblin MR; Miller JL; Ortel B
    Photochem Photobiol; 2000 Oct; 72(4):533-40. PubMed ID: 11045726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scavenger-receptor-mediated delivery of daunomycin elicits selective toxicity towards neoplastic cells of macrophage lineage.
    Mukhopadhyay A; Mukhopadhyay B; Srivastava RK; Basu SK
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):237-41. PubMed ID: 1599401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cationization of protein antigens. I. Alteration of immunogenic properties.
    Muckerheide A; Apple RJ; Pesce AJ; Michael JG
    J Immunol; 1987 Feb; 138(3):833-7. PubMed ID: 2433331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
    Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
    Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that specific oligosaccharides block early events necessary for the expression of antigen-specific proliferation by human lymphocytes.
    Muchmore AV; Decker JM; Blaese RM
    J Immunol; 1980 Sep; 125(3):1306-11. PubMed ID: 6157723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scavenger receptor-mediated recognition of maleylated albumin and its relation to subsequent endocytic degradation.
    Takata K; Horiuchi S; Morino Y
    Biochim Biophys Acta; 1989 Sep; 984(3):273-80. PubMed ID: 2775777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of macrophage lipoprotein lipase secretion by the scavenger receptor.
    Murata Y; Behr SR; Kraemer FB
    Biochim Biophys Acta; 1988 Oct; 972(1):17-24. PubMed ID: 3179335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors.
    Schnitzer JE; Bravo J
    J Biol Chem; 1993 Apr; 268(10):7562-70. PubMed ID: 8463286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of human transfer factor on the migration of guinea-pig macrophages: is there an antigen-specific activity?
    Sargent IL; Salaman MR
    Immunology; 1980 Sep; 41(1):227-35. PubMed ID: 6159314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple method for the assessment of macrophage scavenger receptor-ligand interaction: adherence of erythrocytes coated with oxidized low density lipoprotein and modified albumin to macrophages.
    Beppu M; Hora M; Kikugawa K
    Biol Pharm Bull; 1994 Jan; 17(1):39-46. PubMed ID: 8148814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T cell proliferation in response to E. coli presented by autologous macrophages is antigen specific.
    Mannhalter JW; Zlabinger GJ; Ahmad R; Eibl MM
    Clin Exp Immunol; 1983 Oct; 54(1):95-102. PubMed ID: 6193917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.